Another GPCR signaling pathway related gene, LDLR, whose mutation type has been demonstrated to be closely related with the phenotype of familial hypercholesterolemia [64], was reported to be associated with higher Gleason grade in prostate cancer [65]. This evidence concerns the gene LDLR and prostate carcinoma.